Seeking Alpha

The FDA will convene an advisory panel meeting this week to discuss metal-on-metal hip implants...

The FDA will convene an advisory panel meeting this week to discuss metal-on-metal hip implants made by Johnson & Johnson (JNJ -0.2%) and Zimmer Holding (ZMH -1.8%), which have been the subject of thousands of patient lawsuits. The metal devices have been linked to almost 16,800 adverse events in the U.S. between 2000 and 2011, according regulators, and need more consistent testing to help lower high failure rates that lead to risky replacement surgeries. (draft report)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|